New Foundayo weight loss pill approved by FDA. Here’s what it costs and how it compares to Zepbound
Federal regulators have approved Eli Lilly’s new weight-loss pill, a second daily oral medication to treat obesity and…
Eli Lilly Gets Speedy FDA Nod for Oral GLP-1 Drug, a Competitor to New Novo Nordisk Pill
Eli Lilly now has FDA approval for its GLP-1 obesity pill, introducing a convenient dosing alternative to injections…
Novo Nordisk Shares Hit Annual Low Despite Regulatory Wins
Novo Nordisk shares fall to a 52-week low as analyst downgrades and competitive pressures overshadow two new FDA…
FDA Warns Novo Nordisk Over Possible Unreported Ozempic Side Effects, Deaths
Topline Weight loss drug giant Novo Nordisk has received a warning letter from the U.S. Food and Drug…
Novo Nordisk’s Awiqli Gets FDA Approval for Type II Diabetes
Novo Nordisk NVO announced that the FDA has approved Awiqli injection as the first and only once-weekly, long-acting basal…
Novo Nordisk Secures Fourth FDA Priority Voucher for Wegovy
Novo Nordisk receives another FDA priority review voucher for Wegovy, but its value is uncertain as the program…
Novo Nordisk’s Awiqli Gets FDA Approval for Type II Diabetes
Novo Nordisk NVO announced that the FDA has approved Awiqli injection as the first and only once-weekly, long-acting basal…
Novo Nordisk wins FDA approval for insulin injection for type 2 diabetes
Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Awiqli (insulin icodec-abae) injection…
FDA sends warning letter to Novo Nordisk over Ozempic, Wegovy side effects – WSOC TV
The Food and Drug Administration sent a warning letter to the makers of Ozempic and Wegovy for not…
Novo Nordisk Navigates Patent Expiry and Enhanced Drug Approval
Novo Nordisk gains FDA approval for potent Wegovy HD while facing generic competition in India after semaglutide patent…
FDA Approves Novo Nordisk’s Higher-Dose Wegovy for Obesity Patients
Novo Nordisk NVO announced that the FDA has approved Wegovy HD (once-weekly injectable semaglutide 7.2 mg) to reduce excess…
FDA Letter Puts Novo Nordisk GLP-1 Risks And Valuation In Focus
Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…